Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D.

被引:0
|
作者
M. B. Graeber
S. Kösel
E. Grasbon-Frodl
H. J. Möller
P. Mehraein
机构
[1] Molecular Neuropathology Laboratory,
[2] Department of Neuromorphology,undefined
[3] Max Planck Institute of Neurobiology (formerly Max-Planck-Institute of Psychiatry,undefined
[4] Basic Sciences Institute),undefined
[5] Am Klopferspitz 18a,undefined
[6] D-82152 Martinsried,undefined
[7] Germany e-mail: neuropat@neuro.mpg.de,undefined
[8] Tel.: +49-89-85783666,undefined
[9] Fax: +49-89-89950077,undefined
[10] Molecular Neuropathology Laboratory,undefined
[11] Institute of Neuropathology,undefined
[12] Ludwig Maximilians University,undefined
[13] Munich,undefined
[14] Germany,undefined
[15] Psychiatric Clinic,undefined
[16] Ludwig Maximilians University,undefined
[17] Munich,undefined
[18] Germany,undefined
来源
Neurogenetics | 1998年 / 1卷
关键词
Key words Alzheimer disease; Amyloid plaques; APOE gene; Dementia; Neurofibrillary tangles;
D O I
暂无
中图分类号
学科分类号
摘要
Alois Alzheimer published two papers on the disease which was named after him by Emil Kraepelin in 1910. Each of these papers contains clinical and pathological data on a patient Alzheimer had seen at the hospital. We have previously reported on the rediscovery of tissue sections from Alzheimer's second published case of Alzheimer disease, Johann F., which probably gave the disease its name (Neurogenetics 1997; 1 : 73–80). Here, we describe the histopathology and APOE genotype of Alois Alzheimer's first patient, Auguste D. As in the case of Johann F., a large number of tissue sections belonging to Alzheimer's laboratory, which was later headed by Spielmeyer, were found among material kept at the Institute of Neuropathology of the University of Munich. As described by Alzheimer in his original report (Allg Zeitschr Psychiatr 1907; 64 : 146–148), there were numerous neurofibrillary tangles and many amyloid plaques, especially in the upper cortical layers of this patient. Yet, there was no microscopic evidence for vascular, i.e., arteriosclerotic, lesions. Interestingly, Alzheimer's histological preparations did not include the hippocampus or entorhinal region. The APOE genotype of this patient was shown to be ε3/ε3 by PCR-based restriction enzyme analysis, indicating that mutational screening of the tissue is feasible. The historical importance of the case of Auguste D. lies in the fact that it marks the beginning of research into Alzheimer disease. In addition, neurofibrillary tangles were first described in this brain.
引用
收藏
页码:223 / 228
页数:5
相关论文
共 50 条
  • [31] The APOE Genotype: Modification of Therapeutic Responses in Alzheimer's Disease
    Hanson, Angela J.
    Craft, Suzanne
    Banks, William A.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (01) : 114 - 120
  • [32] Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease
    Tiraboschi, P
    Hansen, LA
    Masliah, E
    Alford, M
    Thal, LJ
    Corey-Bloom, J
    [J]. NEUROLOGY, 2004, 62 (11) : 1977 - 1983
  • [33] Cholesterol and APOE genotype interact to influence Alzheimer disease progression
    Evans, RM
    Hui, S
    Perkins, A
    Lahiri, DK
    Poirier, J
    Farlow, MR
    [J]. NEUROLOGY, 2004, 62 (10) : 1869 - 1871
  • [34] APOE genotype effects on Alzheimer's disease onset and epidemiology
    Ashford, JW
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 23 (03) : 157 - 165
  • [35] Cognitive impairment in Alzheimer's disease is modified by APOE genotype
    van der Vlies, Annelies E.
    Pijnenburg, Yolande A. L.
    Koene, Teddy
    Klein, Martin
    Kok, Astrid
    Scheltens, Philip
    van der Flier, Wiesje M.
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 24 (02) : 98 - 103
  • [36] Pharmacogenetic approaches to the therapy of Alzheimer's disease: A role of APOE genotype
    Selezneva, N
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S407 - S407
  • [37] Patterns of Cortical Thickness according to APOE Genotype in Alzheimer's Disease
    Gutierrez-Galve, Leticia
    Lehmann, Manja
    Hobbs, Nicola Z.
    Clarkson, Matthew J.
    Ridgway, Gerard R.
    Crutch, Sebastian
    Ourselin, Sebastien
    Schott, Jonathan M.
    Fox, Nick C.
    Barnes, Josephine
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 28 (05) : 476 - 485
  • [38] Brain organoids shed light on APOE genotype and Alzheimer disease pathology
    Ian Fyfe
    [J]. Nature Reviews Neurology, 2021, 17 : 1 - 1
  • [39] Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease
    Choi, Seong Hye
    Kim, Sang Yun
    Na, Hae Ri
    Kim, Byung-Kun
    Yang, Dong Won
    Kwon, Jay C.
    Park, Mee Young
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (05) : 445 - 450
  • [40] Cholesterol, APOE genotype, and Alzheimer disease -: An epidemiologic study of Nigerian Yoruba
    Hall, K
    Murrell, J
    Ogunniyi, A
    Deeg, M
    Baiyewu, O
    Gao, S
    Gureje, O
    Dickens, J
    Evans, R
    Smith-Gamble, V
    Unverzagt, FW
    Shen, J
    Hendrie, H
    [J]. NEUROLOGY, 2006, 66 (02) : 223 - 227